Home › Diabetes › NCT07548372

SPARK-CGM Implementation

Supporting Primary Care Adoption, Resources, and Knowledge for Continuous Glucose Monitoring

Who can join

Ages 18 and older · All sexes

Inclusion Criteria:

Clinic level:

* All adult Montefiore primary care sites
* Clinician and clinic staff will be eligible if they provide direct patient care or are involved in CGM prescribing, authorization, onboarding, or education at participating primary care clinics. Eligible clinicians include physicians, nurse practitioners, physician assistants, and clinicians in training. Eligible clinic staff may include nurses, medical assistants, and other relevant administrative staff

Patient level:

* Age 18 years or older
* Receive primary care at participating sites
* Diagnosis of any diabetes mellitus
* Treated with insulin therapy

Exclusion Criteria:

Clinic level:

\- Sites participating in pilot phase of CGM initiative

Patient level:

\- Existing CGM prescription within 24 months before the study start

About the study

Continuous glucose monitoring (CGM) is a technology that helps individuals with diabetes track their sugar levels in real-time, leading to more in-range blood sugars, fewer episodes of dangerously low blood sugar, and improved quality of life. Despite these benefits, CGM is not widely used in primary care settings, where most people receive their diabetes care. The investigators aim to make CGM more accessible and equitably prescribed in primary care practices. The study team will support primary care to increase CGM use with a program called SPARK-CGM (Supporting Primary Care Adoption, Resources, and Knowledge for CGM) across a large network of primary care clinics at Montefiore Medical Center. This program will provide primary care providers (PCPs) with education, tools, and support to incorporate CGM into their routine care for people with diabetes. Investigators plan to test SPARK-CGM to evaluate whether it increases CGM prescriptions who are eligible to receive this technology.

What is being tested

• Enhanced CGM Interventions (other)
• Standard of Care (other)

Sponsor: Montefiore Medical Center · Participants: 20,000 · Started: May 1, 2026

Contact the study team

• Rosina Antwi · Phone: 646-515-8399

Official record on ClinicalTrials.gov — NCT07548372

Locations in the U.S.

Conditions

• Diabetes

From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.